Immunocore Holdings plc
IMCR · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$51,087 | -$43,369 | -$52,543 | -$180,029 |
| Dep. & Amort. | $4,204 | $4,090 | $5,335 | $7,591 |
| Deferred Tax | $0 | $0 | -$3,535 | -$12,693 |
| Stock-Based Comp. | $34,190 | $32,469 | $32,888 | $48,894 |
| Change in WC | $45,129 | $5,782 | -$24,165 | -$21,959 |
| Other Non-Cash | -$6,375 | $3,968 | -$7,189 | $15,090 |
| Operating Cash Flow | $26,061 | $2,940 | -$49,209 | -$143,106 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$5,173 | -$4,256 | -$2,203 | -$1,386 |
| Net Acquisitions | $0 | $0 | $0 | $0 |
| Inv. Purchases | -$350,000 | $0 | $0 | $0 |
| Inv. Sales/Matur. | $0 | $0 | $0 | $0 |
| Other Inv. Act. | $44 | -$1,169 | $6 | $106 |
| Investing Cash Flow | -$355,129 | -$5,425 | -$2,197 | -$1,280 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $352,500 | $0 | $0 | $0 |
| Stock Issued | $0 | $0 | $139,515 | $286,887 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | -$8,619 | $34,346 | $5,927 | $1,298 |
| Financing Cash Flow | $343,881 | $34,346 | $145,442 | $288,185 |
| Forex Effect | -$1,708 | $8,293 | -$12,646 | $625 |
| Net Chg. in Cash | $13,105 | $40,154 | $81,390 | $144,424 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $442,626 | $402,472 | $321,082 | $176,658 |
| End Cash | $455,731 | $442,626 | $402,472 | $321,082 |
| Free Cash Flow | $20,888 | -$2,485 | -$51,412 | -$144,492 |